These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 8195886
1. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P. J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886 [Abstract] [Full Text] [Related]
2. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Bax JJ, Veening MA, Visser FC, van Lingen A, Heine RJ, Cornel JH, Visser CA. Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874 [Abstract] [Full Text] [Related]
3. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A. J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561 [Abstract] [Full Text] [Related]
6. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J. J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389 [Abstract] [Full Text] [Related]
9. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. Schinkel AF, Bax JJ, Valkema R, Elhendy A, van Domburg RT, Vourvouri EC, Bountioukos MA, Krenning EP, Roelandt JR, Poldermans D. J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813 [Abstract] [Full Text] [Related]
10. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration. Kam BL, Valkema R, Poldermans D, Bax JJ, Reijs AE, Rambaldi R, Boersma E, Rietveld T, Roelandt JR, Krenning EP. J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201 [Abstract] [Full Text] [Related]
11. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM, van Lingen A, Teule GJ, Vaalburg W, Lie KI, Visser CA. J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297 [Abstract] [Full Text] [Related]
12. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading]. Brink I, Nitzsche EU, Mix M, Schindler T, Hentschel M, Högerle S, Moser E. Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453 [Abstract] [Full Text] [Related]
17. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J, Sasaki Y. J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509 [Abstract] [Full Text] [Related]
18. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. Mäki MT, Haaparanta M, Nuutila P, Oikonen V, Luotolahti M, Eskola O, Knuuti JM. J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500 [Abstract] [Full Text] [Related]
19. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. Tamaki N, Yonekura Y, Kawamoto M, Magata Y, Sasayama S, Takahashi N, Nohara R, Kambara H, Kawai C, Konishi J. J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154 [Abstract] [Full Text] [Related]